Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I Hypertension

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 655 participants.

Also called NCT00971165

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 655 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT00971165
Other papers using this trial's data
  • Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial Acta diabetologica, 2021-02 DOI, PubMed 33047257 PubMed links an erratum for this paper. Erratum: PMID 33646385
  • Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension: results from the PREVER-treatment randomized trial Journal of hypertension, 2016-04 DOI, PubMed 26938814

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT00971165. Randomized; quadruple masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2014-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I Hypertension
Acronym
PREVER
Condition
Hypertension
Condition
Cardiovascular Disease
Intervention (Drug)
losartan
Intervention (Drug)
Chlorthalidone plus amiloride
Lead sponsor
Hospital de Clinicas de Porto Alegre (class: other)
Collaborator
Financiadora de Estudos e Projetos (class: other)

Record details

Record id
cardio:ct-nct00971165
Content hash
0a517b945edf743e23b5b3b4eab543fc03bea9ddfd41055843dd4a0f70b5d53d